Replies to post #691813 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

It's one possible scenario. How about this one: UCLA buys some Eden units ( If they can be made to work reliably) for Plll trials and Advent trains the staff to use it. This way Advent can handle the billing and whatnot. LOL


They can do more than that currently and, last I read somewhere, they were scaling up.

>>Their maximum production rate is ~1-2 vaccines per month.

[Nemesis18]

So no, I don't think UCLA can handle that scope moving forward. If only there was a biotech company that has patents for manufacturing this product and access to large scale manufacturing assets with which to make vaccines at commercial levels. Wherever could they find a company like that?

Advent might fit the bill, but that’s not owned by NWBO !